NeuroOne Medical Technologies

NeuroOne Medical Technologies EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of NeuroOne Medical Technologies (NMTC) as of Oct 27, 2026 is -4.23 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -12.09 M USD — a change of -65.04% (higher).

EBITDA

-4.23 MUSD

YoY

-65.04%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of NeuroOne Medical Technologies is 2025 -4.23 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of NeuroOne Medical Technologies was 2024 -12.09 M USD. It decreases by -65.04% higher compared to the previous year.

The NeuroOne Medical Technologies EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
-3.21 M USD
Jan 1, 2019
-5.81 M USD
Jan 1, 2020
-4.90 M USD
Jan 1, 2021
-9.95 M USD
Jan 1, 2022
-10.00 M USD
Jan 1, 2023
-11.96 M USD
Jan 1, 2024
-12.09 M USD
Jan 1, 2025
-4.23 M USD
The NeuroOne Medical Technologies EBITDA history
YEAREBITDAYoY
-4.23 MUSD-65.04%
-12.09 MUSD+1.12%
-11.96 MUSD+19.56%
-10.00 MUSD+0.55%
-9.95 MUSD+102.87%
-4.90 MUSD-15.67%
-5.81 MUSD+81.06%
-3.21 MUSD-335.64%
1.36 MUSD-4,507.33%
-30,915.00USD-13.92%
-35,914.00USD+82.94%
-19,632.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

NeuroOne Medical Technologies Stock analysis

What does NeuroOne Medical Technologies do? NeuroOne Medical Technologies Corp., based in Eden Prairie, Minnesota, develops and commercializes thin film electrode technology for medical applications. The company focuses on continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for neurological disorders such as epilepsy, Parkinson's disease, and chronic pain. Listed on the stock market in 2012, NeuroOne employs 15 people and explores AI applications in its technology. NeuroOne Medical Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NeuroOne Medical Technologies stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of NeuroOne Medical Technologies is -4.23 M USD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of NeuroOne Medical Technologies changed from -12.09 M USD to -4.23 M USD, representing a -65.04% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) NeuroOne Medical Technologies since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s NeuroOne Medical Technologies historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — NeuroOne Medical Technologies

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — NeuroOne Medical Technologies